Annual CFF
-$763.50 M
+$80.30 M+9.52%
31 December 2023
Summary:
Zimmer Biomet Holdings annual cash flow from financing activities is currently -$763.50 million, with the most recent change of +$80.30 million (+9.52%) on 31 December 2023. During the last 3 years, it has fallen by -$341.70 million (-81.01%). ZBH annual CFF is now -110.74% below its all-time high of $7.11 billion, reached on 31 December 2015.ZBH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$101.90 M
-$10.00 M-10.88%
30 September 2024
Summary:
Zimmer Biomet Holdings quarterly cash flow from financing activities is currently -$101.90 million, with the most recent change of -$10.00 million (-10.88%) on 30 September 2024. Over the past year, it has increased by +$94.10 million (+48.01%). ZBH quarterly CFF is now -101.35% below its all-time high of $7.57 billion, reached on 31 March 2015.ZBH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$495.30 M
+$94.10 M+15.97%
30 September 2024
Summary:
Zimmer Biomet Holdings TTM cash flow from financing activities is currently -$495.30 million, with the most recent change of +$94.10 million (+15.97%) on 30 September 2024. Over the past year, it has increased by +$330.20 million (+40.00%). ZBH TTM CFF is now -106.59% below its all-time high of $7.51 billion, reached on 30 June 2015.ZBH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBH Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.5% | +48.0% | +40.0% |
| 3 y3 years | -81.0% | +76.1% | +47.1% |
| 5 y5 years | +41.4% | +65.8% | +43.3% |
ZBH Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -81.0% | +41.5% | -103.4% | +84.5% | at high | +65.1% |
| 5 y | 5 years | -81.0% | +41.5% | -106.8% | +93.6% | -158.4% | +76.5% |
| alltime | all time | -110.7% | +41.5% | -101.3% | +93.6% | -106.6% | +78.3% |
Zimmer Biomet Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$101.90 M(+10.9%) | -$495.30 M(-16.0%) |
| June 2024 | - | -$91.90 M(+83.4%) | -$589.40 M(-2.9%) |
| Mar 2024 | - | -$50.10 M(-80.1%) | -$606.90 M(-20.5%) |
| Dec 2023 | -$763.50 M(-9.5%) | -$251.40 M(+28.3%) | -$763.50 M(-7.5%) |
| Sept 2023 | - | -$196.00 M(+79.2%) | -$825.50 M(+0.3%) |
| June 2023 | - | -$109.40 M(-47.1%) | -$823.40 M(-4.3%) |
| Mar 2023 | - | -$206.70 M(-34.0%) | -$860.00 M(+1.9%) |
| Dec 2022 | -$843.80 M(-35.4%) | -$313.40 M(+61.6%) | -$843.80 M(-28.9%) |
| Sept 2022 | - | -$193.90 M(+32.8%) | -$1.19 B(-16.4%) |
| June 2022 | - | -$146.00 M(-23.4%) | -$1.42 B(+9.0%) |
| Mar 2022 | - | -$190.50 M(-71.0%) | -$1.30 B(-0.4%) |
| Dec 2021 | -$1.31 B(+209.6%) | -$655.80 M(+53.9%) | -$1.31 B(+39.5%) |
| Sept 2021 | - | -$426.10 M(+1405.7%) | -$936.50 M(+69.3%) |
| June 2021 | - | -$28.30 M(-85.5%) | -$553.00 M(-73.8%) |
| Mar 2021 | - | -$195.80 M(-31.6%) | -$2.11 B(+400.3%) |
| Dec 2020 | -$421.80 M(-45.9%) | -$286.30 M(+572.1%) | -$421.80 M(+32.6%) |
| Sept 2020 | - | -$42.60 M(-97.3%) | -$318.20 M(-44.6%) |
| June 2020 | - | -$1.59 B(-206.2%) | -$574.00 M(-167.7%) |
| Mar 2020 | - | $1.49 B(-917.1%) | $848.10 M(-208.7%) |
| Dec 2019 | -$779.90 M(-40.1%) | -$182.70 M(-38.8%) | -$779.90 M(-10.6%) |
| Sept 2019 | - | -$298.40 M(+82.4%) | -$872.70 M(+0.1%) |
| June 2019 | - | -$163.60 M(+21.0%) | -$872.00 M(-61.7%) |
| Mar 2019 | - | -$135.20 M(-50.9%) | -$2.28 B(+75.0%) |
| Dec 2018 | -$1.30 B(+7.6%) | -$275.50 M(-7.5%) | -$1.30 B(+3.4%) |
| Sept 2018 | - | -$297.70 M(-81.0%) | -$1.26 B(-1.8%) |
| June 2018 | - | -$1.57 B(-286.6%) | -$1.28 B(+105.3%) |
| Mar 2018 | - | $841.80 M(-461.4%) | -$624.80 M(-48.4%) |
| Dec 2017 | -$1.21 B(+62.9%) | -$232.90 M(-27.4%) | -$1.21 B(-5.9%) |
| Sept 2017 | - | -$320.70 M(-64.9%) | -$1.29 B(+188.0%) |
| June 2017 | - | -$913.00 M(-456.5%) | -$446.80 M(-229.2%) |
| Mar 2017 | - | $256.10 M(-182.9%) | $345.80 M(-146.5%) |
| Dec 2016 | -$743.20 M(-110.5%) | -$309.10 M(-159.5%) | -$743.20 M(-23.6%) |
| Sept 2016 | - | $519.20 M(-531.2%) | -$972.50 M(-40.6%) |
| June 2016 | - | -$120.40 M(-85.5%) | -$1.64 B(+26.3%) |
| Mar 2016 | - | -$832.90 M(+54.7%) | -$1.29 B(-118.2%) |
| Dec 2015 | $7.11 B(-1346.6%) | -$538.40 M(+273.4%) | $7.11 B(-3.7%) |
| Sept 2015 | - | -$144.20 M(-165.3%) | $7.38 B(-1.7%) |
| June 2015 | - | $220.70 M(-97.1%) | $7.51 B(+3.0%) |
| Mar 2015 | - | $7.57 B(-2976.7%) | $7.29 B(-1378.6%) |
| Dec 2014 | -$570.10 M(+22.0%) | -$263.10 M(+1554.7%) | -$570.10 M(+32.8%) |
| Sept 2014 | - | -$15.90 M(+3875.0%) | -$429.20 M(+21.6%) |
| June 2014 | - | -$400.00 K(-99.9%) | -$353.00 M(+15.5%) |
| Mar 2014 | - | -$290.70 M(+137.9%) | -$305.50 M(-34.6%) |
| Dec 2013 | -$467.30 M | -$122.20 M(-302.7%) | -$467.30 M(+15.9%) |
| Sept 2013 | - | $60.30 M(+28.0%) | -$403.20 M(-30.5%) |
| June 2013 | - | $47.10 M(-110.4%) | -$579.80 M(-23.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | -$452.50 M(+678.8%) | -$759.90 M(+74.1%) |
| Dec 2012 | -$436.50 M(-4.2%) | -$58.10 M(-50.0%) | -$436.50 M(+28.0%) |
| Sept 2012 | - | -$116.30 M(-12.6%) | -$340.90 M(-13.4%) |
| June 2012 | - | -$133.00 M(+3.0%) | -$393.60 M(+6.8%) |
| Mar 2012 | - | -$129.10 M(-444.3%) | -$368.40 M(-19.2%) |
| Dec 2011 | -$455.80 M(-6.9%) | $37.50 M(-122.2%) | -$455.80 M(-23.0%) |
| Sept 2011 | - | -$169.00 M(+56.8%) | -$592.30 M(-8.0%) |
| June 2011 | - | -$107.80 M(-50.2%) | -$644.10 M(+4.2%) |
| Mar 2011 | - | -$216.50 M(+118.7%) | -$618.20 M(+26.3%) |
| Dec 2010 | -$489.60 M(+86.8%) | -$99.00 M(-55.2%) | -$489.60 M(+26.1%) |
| Sept 2010 | - | -$220.80 M(+169.6%) | -$388.40 M(+34.0%) |
| June 2010 | - | -$81.90 M(-6.8%) | -$289.90 M(+14.1%) |
| Mar 2010 | - | -$87.90 M(-4095.5%) | -$254.10 M(-3.1%) |
| Dec 2009 | -$262.10 M(-23.7%) | $2.20 M(-101.8%) | -$262.10 M(+31.3%) |
| Sept 2009 | - | -$122.30 M(+165.3%) | -$199.60 M(+71.3%) |
| June 2009 | - | -$46.10 M(-51.9%) | -$116.50 M(-62.8%) |
| Mar 2009 | - | -$95.90 M(-248.2%) | -$313.50 M(-8.7%) |
| Dec 2008 | -$343.50 M(-14.0%) | $64.70 M(-265.1%) | -$343.50 M(-33.9%) |
| Sept 2008 | - | -$39.20 M(-83.9%) | -$519.40 M(-16.4%) |
| June 2008 | - | -$243.10 M(+93.1%) | -$621.00 M(+37.7%) |
| Mar 2008 | - | -$125.90 M(+13.2%) | -$451.00 M(+12.9%) |
| Dec 2007 | -$399.50 M(-45.3%) | -$111.20 M(-21.0%) | -$399.50 M(-8.4%) |
| Sept 2007 | - | -$140.80 M(+92.6%) | -$436.00 M(-24.9%) |
| June 2007 | - | -$73.10 M(-1.7%) | -$580.50 M(-28.4%) |
| Mar 2007 | - | -$74.40 M(-49.6%) | -$810.90 M(+11.0%) |
| Dec 2006 | -$730.70 M(+50.8%) | -$147.70 M(-48.2%) | -$730.70 M(+24.8%) |
| Sept 2006 | - | -$285.30 M(-6.0%) | -$585.50 M(+28.1%) |
| June 2006 | - | -$303.50 M(-5332.8%) | -$457.20 M(+52.2%) |
| Mar 2006 | - | $5.80 M(-332.0%) | -$300.30 M(-38.0%) |
| Dec 2005 | -$484.60 M(+20.5%) | -$2.50 M(-98.4%) | -$484.60 M(-5.4%) |
| Sept 2005 | - | -$157.00 M(+7.1%) | -$512.10 M(-3.8%) |
| June 2005 | - | -$146.60 M(-17.9%) | -$532.40 M(+13.8%) |
| Mar 2005 | - | -$178.50 M(+495.0%) | -$467.70 M(+16.3%) |
| Dec 2004 | -$402.00 M(-160.5%) | -$30.00 M(-83.1%) | -$402.00 M(-220.9%) |
| Sept 2004 | - | -$177.30 M(+116.5%) | $332.50 M(-35.9%) |
| June 2004 | - | -$81.90 M(-27.4%) | $519.00 M(-14.4%) |
| Mar 2004 | - | -$112.80 M(-116.0%) | $606.30 M(-8.8%) |
| Dec 2003 | $664.80 M(-451.9%) | $704.50 M(+7557.6%) | $664.80 M(-660.1%) |
| Sept 2003 | - | $9.20 M(+70.4%) | -$118.70 M(-34.1%) |
| June 2003 | - | $5.40 M(-109.9%) | -$180.00 M(-18.8%) |
| Mar 2003 | - | -$54.30 M(-31.3%) | -$221.80 M(+17.4%) |
| Dec 2002 | -$188.90 M(+90.6%) | -$79.00 M(+51.6%) | -$188.90 M(+71.9%) |
| Sept 2002 | - | -$52.10 M(+43.1%) | -$109.90 M(+90.1%) |
| June 2002 | - | -$36.40 M(+70.1%) | -$57.80 M(+170.1%) |
| Mar 2002 | - | -$21.40 M | -$21.40 M |
| Dec 2001 | -$99.10 M(-51.3%) | - | - |
| Dec 2000 | -$203.40 M | - | - |
FAQ
- What is Zimmer Biomet Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings annual CFF year-on-year change?
- What is Zimmer Biomet Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings quarterly CFF year-on-year change?
- What is Zimmer Biomet Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Zimmer Biomet Holdings?
- What is Zimmer Biomet Holdings TTM CFF year-on-year change?
What is Zimmer Biomet Holdings annual cash flow from financing activities?
The current annual CFF of ZBH is -$763.50 M
What is the all time high annual CFF for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high annual cash flow from financing activities is $7.11 B
What is Zimmer Biomet Holdings annual CFF year-on-year change?
Over the past year, ZBH annual cash flow from financing activities has changed by +$80.30 M (+9.52%)
What is Zimmer Biomet Holdings quarterly cash flow from financing activities?
The current quarterly CFF of ZBH is -$101.90 M
What is the all time high quarterly CFF for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high quarterly cash flow from financing activities is $7.57 B
What is Zimmer Biomet Holdings quarterly CFF year-on-year change?
Over the past year, ZBH quarterly cash flow from financing activities has changed by +$94.10 M (+48.01%)
What is Zimmer Biomet Holdings TTM cash flow from financing activities?
The current TTM CFF of ZBH is -$495.30 M
What is the all time high TTM CFF for Zimmer Biomet Holdings?
Zimmer Biomet Holdings all-time high TTM cash flow from financing activities is $7.51 B
What is Zimmer Biomet Holdings TTM CFF year-on-year change?
Over the past year, ZBH TTM cash flow from financing activities has changed by +$330.20 M (+40.00%)